Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting - Board Meeting On August 08, 2018

 With respect to the captioned subject, please be informed that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Wednesday, 8th August, 2018 inter alia, to consider, the Un-audited Financial Results for the quarter ended on 30th June, 2018. Further, the Trading Window in respect of the Company's Securities shall remain closed for all Directors/Officers/Designated Employees of the Company from the opening...
17-07-2018
Bigul

FDA order may sink Themis Medicare

 Themis Medicare, maker of diclofenac 1 ml injection, has been directed by the Food and Drug Administration authorities to stop manufacturing a key pro
13-07-2018
Bigul

Announcement Under Regulation 30 (LODR) (Letter Received From FDA Authorities)

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we, hereby, inform you that the Company has received a letter dated 11th July, 2018 from the Food and Drug Administration (FDA) authorities directing, inter alia, not to manufacture a key product till deciding of the matter. The Company has been given an opportunity to be heard and is taking necessary steps to suitably reply to the said letter....
12-07-2018
Bigul

Shareholding for the Period Ended June 30, 2018

 Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here
12-07-2018
Bigul

Shareholding for the Period Ended June 30, 2018

 Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here
12-07-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended June 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Mr. Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer
09-07-2018
Bigul

Announcement under Regulation 30 (LODR)-Credit Rating

 We hereby inform you that Credit Rating assigned to the Company has been revised by the Credit Rating Agency i.e CARE Ratings Limited ('CARE'). The Company's rating for Long Term Bank Facilities have been revised by CARE from CARE BB; Stable to CARE D. The rating for Long Term / Short Term Bank Facilities have been revised by CARE from CARE BB; Stable /CAREA4 to CARE D. The Copy of the same is enclosed herewith for your reference. This is for your information and record.
20-06-2018
Bigul

Disclosure Verification

 In response to the Exchange Query, Themis Medicare Ltd has submitted to BSE a copy of Clarification is enclosed.
06-06-2018
Bigul

Financial Results For The Year Ended 31St March, 2018

 The Board of Directors at its meeting held today, inter alia, considered and approved the the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2018. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2018 is enclosed herewith. As reported in the attached Independent Auditor''s Report, the figures of quarter ended March 31, 2018 and...
09-05-2018
Bigul

Outcome of Board Meeting (AGM on Sept 07, 2018)

 Themis Medicare Ltd has informed BSE about Outcome of Board Meeting held on May 09, 2018.
09-05-2018
Next Page
Close

Let's Open Free Demat Account